arrow
返回
H

Hong Yang

kunming medical university

46H指数
399论文数
8.3K被引数
收录论文 138
发表时间
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trialfruizolapari布联合或不联合阿帕替尼作为新诊断、晚期卵巢癌的维持治疗(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照的III期临床试验
err2025-11-25
err0
errOAAI
errLingying Wu MD; Jing Wang MD; Qingshui Li BS; Danbo Wang PhD; Cuiying Zhang MM; Junying Tang MD; Guonan Zhang BS; Min Hao PhD; Desheng Yao MD, PhD; Qinglei Gao MD; Youzhong Zhang PhD; Ruifang An MD; Rutie Yin MD; Li Wang BS; Bairong Xia MD; Qi Zhou MS; Hongying Yang MM; Jianqing Zhu MD; Kui Jiang MM; Zhengzheng Chen MM; Qiang Wu MD; Wei Duan MM; Yi Huang MM; Hui Zhang PhD; Shuqing Wei MM; Guiling Li MD; Yuanguang Meng MD; Ke Wang MM; Xinfeng Yang BS; Xianghua Huang PhD; Lingya Pan MD; Jinjin Yu BS; Ge Lou PhD; Yu Zhang PhD; Huaijun Zhou MD; Xiaoqing Guo MD, PhD; Hong Yang PhD; Xiaodong Cheng MD; Xiumin Li MM; Wuliang Wang MD; Hongqin Zhao BS; Yunxia Li BS; Yingjie Yang PhD; An Lin BS; Wenjun Cheng MD; Lihong Chen MD; Xiaoying Xie BS; Wen Di MD, PhD; Yuanjing Hu MD; Mo Chen MD; Hongwu Wen MD; Liping Cai MM; Xiaohua Wu MD, PhD; Zhongqiu Lin MD, PhD; Quanren Wang PhD; Xinfeng Yang PhD; Ning Li MD
err分享
err收藏
Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma循环肿瘤DNA作为切除的食管鳞状细胞癌中分子残留病灶的标志物
err2025-09-18
err0
errOAAI
errCai-Yan Fang; Jing Wen; Jia-Di Wu; Zhi-Chao Li; Sheng Huang; Yan Huang; Ji-Yang Chen; Hui-Lin Su; Xiu-Ying Xie; Kong-Jia Luo; Jian-Hua Fu; Hong Yang
err分享
err收藏
Nano-Emulsion Incorporating Squalene and Mn2+ Stabilized by TA/Mn2+ Networks Enhances Subunit Vaccine Immunogenicity由TA/Mn2+网络稳定的、包含角鲨烯和Mn2+的纳米乳液增强了亚单位疫苗的免疫原性
err2025-09-18
err0
errOAAI
errKai Chen; Linlin Li; Ning Wang; Yunfeng Deng; Chuanying Xiang; Xiaomin Zhang; Yangyang Zhou; Hong Yang; Yu Xie; Xiaoting Chen; Ying Li; Yan Li; Gang Guo; Yun Shi
err分享
err收藏
Real-world applications of postneoadjuvant stage I of the staging system for oesophageal squamous cell cancer: what is beyond a pathological complete response?
err2025-07-01
err0
PREAI
errHuang, Yan; Li, Zhichao; Wu, Jiadi; Huang, Sheng; Fang, Caiyan; Li, Kaiwen; Chen, Jiyang; Su, Huilin; Yang, Hong; Luo, Kongjia; Fu, Jianhua
err分享
err收藏
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
err2025-01-06
err0
errOAAI
errYulug, Burak; Altay, Ozlem; Li, Xiangyu; Hanoglu, Lutfu; Cankaya, Seyda; Velioglu, Halil A.; Lam, Simon; Yang, Hong; Coskun, Ebru; Idil, Ezgi; Bayraktaroglu, Zubeyir; Nogaylar, Rahim; Ozsimsek, Ahmet; Yildirim, Serkan; Bolat, Ismail; Kiliclioglu, Metin; Bayram, Cemil; Yuksel, Nursena; Tozlu, Ozlem O.; Arif, Muhammad; Shoaie, Saeed; Hacimuftuoglu, Ahmet; Zhang, Cheng; Nielsen, Jens; Turkez, Hasan; Boren, Jan; Uhlen, Mathias; Mardinoglu, Adil
err分享
err收藏
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
err2024-12-01
err3
PREAI
errZhao, Ze-Rui; Liu, Shi-Liang; Zhou, Ting; Chen, Gang; Long, Hao; Su, Xiao-Dong; Zhang, Xu; Fu, Jian-Hua; Lin, Peng; Zhang, Lan-Jun; Rong, Tie-Hua; Wu, Jia-Di; Li, Zhi-Chao; Su, Hui-Lin; Chen, Ji-Yang; Yang, Yun-Peng; Lin, Yong-Bin; Xi, Mian; Yang, Hong
err分享
err收藏
Cell Membrane-Coated Nanotherapeutics for the Targeted Treatment of Acute and Chronic Colitis
err2024-11-07
err0
errOAAI
errLi, Shan; Chen, Lei; Wu, Tianyu; Wu, Jingfeng; Yang, Hong; Ju, Qian; Liu, Zhicheng; Chen, Wensheng; Zhang, Dinglin; Hao, Yingxue
err分享
err收藏